Fmr LLC Boosts Position in Humana Inc (HUM)

Fmr LLC increased its position in Humana Inc (NYSE:HUM) by 12.7% in the second quarter, HoldingsChannel reports. The firm owned 12,212,514 shares of the insurance provider’s stock after purchasing an additional 1,374,030 shares during the quarter. Humana accounts for 0.4% of Fmr LLC’s holdings, making the stock its 29th biggest holding. Fmr LLC owned about 0.09% of Humana worth $3,634,811,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Sun Life Financial INC grew its stake in Humana by 120.7% in the second quarter. Sun Life Financial INC now owns 373 shares of the insurance provider’s stock worth $111,000 after purchasing an additional 204 shares in the last quarter. Financial Gravity Wealth Inc. acquired a new position in Humana in the first quarter worth about $113,000. Migdal Insurance & Financial Holdings Ltd. grew its stake in Humana by 2,984.6% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 401 shares of the insurance provider’s stock worth $119,000 after purchasing an additional 388 shares in the last quarter. Summit Trail Advisors LLC grew its stake in Humana by 24,611.8% in the first quarter. Summit Trail Advisors LLC now owns 184,103 shares of the insurance provider’s stock worth $184,000 after purchasing an additional 183,358 shares in the last quarter. Finally, NuWave Investment Management LLC acquired a new position in Humana in the second quarter worth about $198,000. Institutional investors and hedge funds own 92.84% of the company’s stock.

HUM has been the topic of a number of recent research reports. Bank of America raised their target price on shares of Humana from $338.00 to $375.00 and gave the stock a “buy” rating in a report on Thursday, August 2nd. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $377.00 target price on the stock in a report on Thursday, October 4th. Piper Jaffray Companies raised their target price on shares of Humana from $326.00 to $350.00 and gave the stock an “overweight” rating in a report on Friday, July 6th. ValuEngine raised shares of Humana from a “hold” rating to a “buy” rating in a report on Wednesday, July 4th. Finally, BMO Capital Markets raised their target price on shares of Humana from $328.00 to $355.00 and gave the stock an “outperform” rating in a report on Monday, June 25th. Seven investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $339.79.

Shares of NYSE HUM opened at $328.38 on Friday. The company has a current ratio of 1.43, a quick ratio of 1.43 and a debt-to-equity ratio of 0.47. Humana Inc has a 52-week low of $231.90 and a 52-week high of $341.30. The stock has a market capitalization of $45.20 billion, a price-to-earnings ratio of 28.57, a price-to-earnings-growth ratio of 1.63 and a beta of 0.97.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, August 1st. The insurance provider reported $3.96 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.79 by $0.17. The company had revenue of $14.26 billion for the quarter, compared to analysts’ expectations of $14.16 billion. Humana had a return on equity of 17.43% and a net margin of 2.48%. During the same quarter in the previous year, the company posted $3.49 earnings per share. As a group, analysts anticipate that Humana Inc will post 14.18 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 26th. Stockholders of record on Friday, September 28th will be issued a dividend of $0.50 per share. The ex-dividend date is Thursday, September 27th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.61%. Humana’s dividend payout ratio (DPR) is presently 17.08%.

In other news, insider Roy A. Beveridge sold 14,306 shares of Humana stock in a transaction that occurred on Monday, August 6th. The stock was sold at an average price of $324.25, for a total transaction of $4,638,720.50. Following the sale, the insider now owns 15,274 shares of the company’s stock, valued at $4,952,594.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Bruce D. Broussard sold 18,000 shares of Humana stock in a transaction that occurred on Monday, September 10th. The shares were sold at an average price of $328.66, for a total value of $5,915,880.00. Following the sale, the chief executive officer now directly owns 71,085 shares in the company, valued at approximately $23,362,796.10. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 40,284 shares of company stock worth $13,147,715. Corporate insiders own 0.60% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Featured Story: What is intrinsic value?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply